ENO2 and lung carcinoma: Moreover, IM-Index out-performed five different lung cancer-specific peripheral blood biomarkers (CEA, CYFRA19, NSE, ProGRP, and SCC) for malignant cancer diagnosis (Fig. 2D; Table 2).